Cystic fibrosis: Diagnostic considerations

Beryl J Rosenstein, T. S. Langbaum, S. J. Metz

Research output: Contribution to journalArticle

Abstract

With an estimated incidence as high as 1:2000 in caucasians, cystic fibrosis (CF) is the most common lethal inherited disorder in the United States. The condition also occurs in 1 of 17,000 American blacks and has been reported rarely in American Indians and orientals. The major clinical features are exocrine pancreatic insufficiency, chronic obstructive pulmonary disease and increased loss of electrolytes in the sweat. The basic defect is unknown, but most of the clinical manifestations can be related to obstruction of organ passages by mucus secretions which exhibit abnormal physicochemical behavior. Screening for CF in the newborn period has been advocated based on the observation of improved outcome with early intervention as a means of providing information for genetic counseling, and for purposes of enumeration and research. The sweat test has not been useful for screening because of expense and difficulty in obtaining an adequate quantity of sweat in the newborn period. The most widely used screening tests are those based on the presence of increased amounts of protein in meconium secondary to deficiency of pancreatic proteolytic enzymes. Protein can be detected semiquantitatively with a test strip or by a radial immunodiffusion technique. These tests will not identify those patients with residual pancreatic function. There may be false-positive values in the presence of prematurity and melena, and false-negative values have been reported in patients with pancreatic insufficiency. A recently proposed screening procedure involved the use of dried blood spots for assay of immunoreactive trypsin, which may be increased in the early stage of CF, including patients with residual pancreatic function.

Original languageEnglish (US)
Pages (from-to)113-120
Number of pages8
JournalThe Johns Hopkins medical journal
Volume150
Issue number3
StatePublished - 1982

Fingerprint

Sweat
Cystic Fibrosis
Exocrine Pancreatic Insufficiency
Newborn Infant
Melena
Meconium
North American Indians
Immunodiffusion
Genetic Counseling
Mucus
Trypsin
Chronic Obstructive Pulmonary Disease
Electrolytes
Proteins
Peptide Hydrolases
Observation
Incidence
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rosenstein, B. J., Langbaum, T. S., & Metz, S. J. (1982). Cystic fibrosis: Diagnostic considerations. The Johns Hopkins medical journal, 150(3), 113-120.

Cystic fibrosis : Diagnostic considerations. / Rosenstein, Beryl J; Langbaum, T. S.; Metz, S. J.

In: The Johns Hopkins medical journal, Vol. 150, No. 3, 1982, p. 113-120.

Research output: Contribution to journalArticle

Rosenstein, BJ, Langbaum, TS & Metz, SJ 1982, 'Cystic fibrosis: Diagnostic considerations', The Johns Hopkins medical journal, vol. 150, no. 3, pp. 113-120.
Rosenstein, Beryl J ; Langbaum, T. S. ; Metz, S. J. / Cystic fibrosis : Diagnostic considerations. In: The Johns Hopkins medical journal. 1982 ; Vol. 150, No. 3. pp. 113-120.
@article{643c00e7e4c24fc39c743363ac0cbc56,
title = "Cystic fibrosis: Diagnostic considerations",
abstract = "With an estimated incidence as high as 1:2000 in caucasians, cystic fibrosis (CF) is the most common lethal inherited disorder in the United States. The condition also occurs in 1 of 17,000 American blacks and has been reported rarely in American Indians and orientals. The major clinical features are exocrine pancreatic insufficiency, chronic obstructive pulmonary disease and increased loss of electrolytes in the sweat. The basic defect is unknown, but most of the clinical manifestations can be related to obstruction of organ passages by mucus secretions which exhibit abnormal physicochemical behavior. Screening for CF in the newborn period has been advocated based on the observation of improved outcome with early intervention as a means of providing information for genetic counseling, and for purposes of enumeration and research. The sweat test has not been useful for screening because of expense and difficulty in obtaining an adequate quantity of sweat in the newborn period. The most widely used screening tests are those based on the presence of increased amounts of protein in meconium secondary to deficiency of pancreatic proteolytic enzymes. Protein can be detected semiquantitatively with a test strip or by a radial immunodiffusion technique. These tests will not identify those patients with residual pancreatic function. There may be false-positive values in the presence of prematurity and melena, and false-negative values have been reported in patients with pancreatic insufficiency. A recently proposed screening procedure involved the use of dried blood spots for assay of immunoreactive trypsin, which may be increased in the early stage of CF, including patients with residual pancreatic function.",
author = "Rosenstein, {Beryl J} and Langbaum, {T. S.} and Metz, {S. J.}",
year = "1982",
language = "English (US)",
volume = "150",
pages = "113--120",
journal = "Johns Hopkins Medical Journal",
issn = "0021-7263",
publisher = "Johns Hopkins University Press",
number = "3",

}

TY - JOUR

T1 - Cystic fibrosis

T2 - Diagnostic considerations

AU - Rosenstein, Beryl J

AU - Langbaum, T. S.

AU - Metz, S. J.

PY - 1982

Y1 - 1982

N2 - With an estimated incidence as high as 1:2000 in caucasians, cystic fibrosis (CF) is the most common lethal inherited disorder in the United States. The condition also occurs in 1 of 17,000 American blacks and has been reported rarely in American Indians and orientals. The major clinical features are exocrine pancreatic insufficiency, chronic obstructive pulmonary disease and increased loss of electrolytes in the sweat. The basic defect is unknown, but most of the clinical manifestations can be related to obstruction of organ passages by mucus secretions which exhibit abnormal physicochemical behavior. Screening for CF in the newborn period has been advocated based on the observation of improved outcome with early intervention as a means of providing information for genetic counseling, and for purposes of enumeration and research. The sweat test has not been useful for screening because of expense and difficulty in obtaining an adequate quantity of sweat in the newborn period. The most widely used screening tests are those based on the presence of increased amounts of protein in meconium secondary to deficiency of pancreatic proteolytic enzymes. Protein can be detected semiquantitatively with a test strip or by a radial immunodiffusion technique. These tests will not identify those patients with residual pancreatic function. There may be false-positive values in the presence of prematurity and melena, and false-negative values have been reported in patients with pancreatic insufficiency. A recently proposed screening procedure involved the use of dried blood spots for assay of immunoreactive trypsin, which may be increased in the early stage of CF, including patients with residual pancreatic function.

AB - With an estimated incidence as high as 1:2000 in caucasians, cystic fibrosis (CF) is the most common lethal inherited disorder in the United States. The condition also occurs in 1 of 17,000 American blacks and has been reported rarely in American Indians and orientals. The major clinical features are exocrine pancreatic insufficiency, chronic obstructive pulmonary disease and increased loss of electrolytes in the sweat. The basic defect is unknown, but most of the clinical manifestations can be related to obstruction of organ passages by mucus secretions which exhibit abnormal physicochemical behavior. Screening for CF in the newborn period has been advocated based on the observation of improved outcome with early intervention as a means of providing information for genetic counseling, and for purposes of enumeration and research. The sweat test has not been useful for screening because of expense and difficulty in obtaining an adequate quantity of sweat in the newborn period. The most widely used screening tests are those based on the presence of increased amounts of protein in meconium secondary to deficiency of pancreatic proteolytic enzymes. Protein can be detected semiquantitatively with a test strip or by a radial immunodiffusion technique. These tests will not identify those patients with residual pancreatic function. There may be false-positive values in the presence of prematurity and melena, and false-negative values have been reported in patients with pancreatic insufficiency. A recently proposed screening procedure involved the use of dried blood spots for assay of immunoreactive trypsin, which may be increased in the early stage of CF, including patients with residual pancreatic function.

UR - http://www.scopus.com/inward/record.url?scp=0020076034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020076034&partnerID=8YFLogxK

M3 - Article

C2 - 7038245

AN - SCOPUS:0020076034

VL - 150

SP - 113

EP - 120

JO - Johns Hopkins Medical Journal

JF - Johns Hopkins Medical Journal

SN - 0021-7263

IS - 3

ER -